Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$78.71 - $87.02 $15,584 - $17,229
-198 Reduced 1.7%
11,427 $899,000
Q1 2024

May 01, 2024

BUY
$82.84 - $88.09 $35,207 - $37,438
425 Added 3.79%
11,625 $1.01 Million
Q4 2023

Jan 22, 2024

SELL
$69.43 - $83.43 $37,422 - $44,968
-539 Reduced 4.59%
11,200 $922,000
Q3 2023

Oct 20, 2023

BUY
$78.22 - $90.4 $61,715 - $71,325
789 Added 7.21%
11,739 $919,000
Q2 2023

Aug 04, 2023

SELL
$79.47 - $91.38 $4,609 - $5,300
-58 Reduced 0.53%
10,950 $964,000
Q1 2023

Apr 25, 2023

BUY
$76.72 - $87.58 $85,926 - $98,089
1,120 Added 11.33%
11,008 $887,000
Q4 2022

Feb 02, 2023

BUY
$76.18 - $87.74 $117,926 - $135,821
1,548 Added 18.56%
9,888 $768,000
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $139,616 - $164,790
-1,729 Reduced 17.17%
8,340 $673,000
Q2 2022

Aug 10, 2022

BUY
$87.4 - $113.09 $880,030 - $1.14 Million
10,069 New
10,069 $897,000
Q3 2015

Aug 21, 2019

SELL
N/A
-5,076 Closed
0 $0
Q1 2015

Aug 21, 2019

BUY
N/A
5,076
5,076 $396,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Ascent Wealth Partners, LLC Portfolio

Follow Ascent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Wealth Partners, LLC with notifications on news.